SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-046001
Filing Date
2013-08-14
Accepted
2013-08-14 18:29:06
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v351650_10q.htm 10-Q 483264
2 EXHIBIT 31.1 v351650_ex31-1.htm EX-31.1 7758
3 EXHIBIT 31.2 v351650_ex31-2.htm EX-31.2 7743
4 EXHIBIT 32.1 v351650_ex32-1.htm EX-32.1 4076
5 EXHIBIT 32.2 v351650_ex32-2.htm EX-32.2 4157
  Complete submission text file 0001144204-13-046001.txt   8383937

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nltx-20130630.xml EX-101.INS 768115
7 XBRL TAXONOMY EXTENSION SCHEMA nltx-20130630.xsd EX-101.SCH 59886
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nltx-20130630_cal.xml EX-101.CAL 26255
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nltx-20130630_def.xml EX-101.DEF 317044
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nltx-20130630_lab.xml EX-101.LAB 373680
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nltx-20130630_pre.xml EX-101.PRE 336414
Mailing Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402
Business Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402 650-458-2678
Nile Therapeutics, Inc. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 131039803
SIC: 2834 Pharmaceutical Preparations